SpringWorks Therapeutics' Spinoff / Spinout Round

SpringWorks Therapeutics raised a round of funding on September 01, 2017. Investors include Pfizer.

SpringWorks Therapeutics is focused on underserved patient populations moving forward potential programs for four diseases (desmoid tumor, Neurofibromatosis, Hereditary xerocytosis, Post-traumatic str…

Articles about SpringWorks Therapeutics' Spinoff / Spinout Round: